Co-Crystallization of the Anti-Cholesterol Drug Bezafibrate: Molecular Recognition of a Pharmaceutical Contaminant in the Solid State and Solution via Hydrogen Bonding

Jesus Loya; Jinchun Qiu; Daniel K. Unruh; Anthony Cozzolino; Kristin Hutchins

Co-Crystallization of the Anti-Cholesterol Drug Bezafibrate: Molecular Recognition of a Pharmaceutical Contaminant in the Solid State and Solution via Hydrogen Bonding

Jesus Loya, Jinchun Qiu, Daniel K. Unruh, Anthony Cozzolino, Kristin Hutchins

Chemistry and Biochemistry

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	4838-4843
Journal	Default journal
State	Published - Aug 13 2018

Cite this

@article{f5ffcd0b9f8d40718842eb53240cac38,

title = "Co-Crystallization of the Anti-Cholesterol Drug Bezafibrate: Molecular Recognition of a Pharmaceutical Contaminant in the Solid State and Solution via Hydrogen Bonding",

author = "Jesus Loya and Jinchun Qiu and Unruh, {Daniel K.} and Anthony Cozzolino and Kristin Hutchins",

year = "2018",

month = aug,

day = "13",

language = "English",

pages = "4838--4843",

journal = "Default journal",

publisher = "Current Opinion in Endocrinology Diabetes and Obesity",

}

TY - JOUR

T1 - Co-Crystallization of the Anti-Cholesterol Drug Bezafibrate: Molecular Recognition of a Pharmaceutical Contaminant in the Solid State and Solution via Hydrogen Bonding

AU - Loya, Jesus

AU - Qiu, Jinchun

AU - Unruh, Daniel K.

AU - Cozzolino, Anthony

AU - Hutchins, Kristin

PY - 2018/8/13

Y1 - 2018/8/13

M3 - Article

SP - 4838

EP - 4843

JO - Default journal

JF - Default journal

ER -

Co-Crystallization of the Anti-Cholesterol Drug Bezafibrate: Molecular Recognition of a Pharmaceutical Contaminant in the Solid State and Solution via Hydrogen Bonding

Fingerprint

Cite this